Associations Between Asthma Control, Adherence and Short-Acting Beta2-Agonist (SABA) Use in Patients With Uncontrolled Asthma Using a Maintenance and Reliever Digital System (MRDS)

被引:0
|
作者
Mosnaim, G. [1 ]
Hoyte, F. [2 ]
Safioti, G. [3 ]
Magnus, N. [4 ]
Brown, R. [5 ]
Hill, T. [5 ]
Sagalovich, K. [6 ]
Wechsler, M. E. [2 ]
机构
[1] NorthShore Univ Hlth Syst, Evanston, IL USA
[2] Natl Jewish Hlth, Denver, CO USA
[3] Teva Pharmaceut Europe BV, Amsterdam, Netherlands
[4] Teva Canada Ltd, Montreal, PQ, Canada
[5] Teva Branded Pharmaceut Prod R&D Inc, Parsippany, NJ USA
[6] Teva Branded Pharmaceut Ind Ltd, Tel Aviv, Israel
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A3021
引用
收藏
页数:2
相关论文
共 50 条
  • [1] SHORT-ACTING BETA2-AGONIST USE REDUCTION AMONG PATIENTS WITH UNCONTROLLED ASTHMA USING A RELIEVER DIGITAL SYSTEM
    Hoyte, F.
    Mosnaim, G.
    Safioti, G.
    Brown, R.
    Hill, T.
    Boe, A.
    Li, T.
    Wechsler, M.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S40 - S40
  • [2] The history and future of short-acting beta2-agonist therapy in asthma
    Hills, Thomas
    Beasley, Richard
    [J]. RESPIROLOGY, 2020, 25 (03) : 246 - 248
  • [3] Assessing Asthma Control in the United States by Examining the Relationships Between Short-Acting Beta2-Agonist and Systemic Corticosteroid Use
    Bleecker, E. R.
    Murphy, K. R.
    Gandhi, H. N.
    Gilbert, I.
    Chupp, G.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [4] DIFFERENCES IN EXACERBATION PATTERNS AND SHORT-ACTING BETA2-AGONIST USE IN PATIENTS WITH MILD VS MODERATE/SEVERE ASTHMA
    Lugogo, N.
    Gilbert, I.
    Gandhi, H.
    Pollack, M.
    Surmont, F.
    Tkacz, J.
    Moore-Schiltz, L.
    Goshi, N.
    Lanz, M.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S32 - S32
  • [5] INHALER TECHNIQUE MAINTENANCE IN PATIENTS WITH UNCONTROLLED ASTHMA USING A RELIEVER DIGITAL SYSTEM
    Hoyte, F.
    Mosnaim, G.
    Safioti, G.
    Brown, R.
    Hill, T.
    Boe, A.
    Sagalovich, K.
    Wechsler, M.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S41 - S42
  • [6] National expert consensus on short-acting beta2-agonist overreliance in asthma care in Malaysia
    Ban, Andrea Yu-Lin
    Taher, Sri Wahyu
    Muneswarao, Jaya
    Ho, Bee Kiau
    Ahmad, Rashidi
    Pereirasamy, Lalitha
    Chong, Li Yin
    Jamal, Shamsuriani Md
    Alaga, Arvindran
    Mydin, Helmy Haja
    Chang, Li Cheng
    Isa, Nor Azila Md
    Zim, Mohd Arif Mohd
    [J]. JOURNAL OF ASTHMA, 2024,
  • [7] Trends of short-acting beta-agonist (SABA) surrounding days of high use in asthma and COPD
    Hoch, Heather
    Gondalia, Rahul
    Anderson, William
    Barrett, Meredith
    Szefler, Stanley
    Van Sickle, David
    Stempel, David
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [8] Retrospective Analysis on the Use of short-acting Beta-2 Sympathomimetics (SABA) in Patients with Asthma in Germany
    Worth, Heinrich
    Criee, Carl Peter
    Vogelmeier, Claus F.
    Kardos, Peter
    Becker, Eva-Maria
    Kostev, Karel
    Mokros, Ingo
    Schneider, Andrea
    [J]. INTERNIST, 2020, 61 (SUPPL 1): : S61 - S61
  • [9] EXPOSURE TO SYSTEMIC CORTICOSTEROIDS AMONG US PATENTS ASTHMA: RISKS ASSOCIATED WITH SHORT-ACTING BETA2-AGONIST USE
    Lanz, Miguel J.
    Pollack, Michael
    Gilbert, Ileen
    Gandhi, Hitesh N.
    Tkacz, Joseph
    Lugogo, Njira L.
    [J]. CHEST, 2022, 162 (04) : 48A - 49A
  • [10] Short-Acting Beta2-Agonist Use in Asthma in Korea: A 10-Year Population-Based Study
    Lee, Hyun
    Ryu, Jiin
    Chung, Sung Jun
    Yeo, Yoomi
    Park, Tai Sun
    Park, Dong Won
    Moon, Ji-Yong
    Kim, Tae-Hyung
    Sohn, Jang Won
    Yoon, Ho Joo
    Kim, Sang-Heon
    [J]. ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2021, 13 (06) : 945 - 953